Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin
- 1 June 1997
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 4 (6), 461-471
- https://doi.org/10.1016/s1074-5521(97)90198-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Delayed extraction matrix‐assisted laser desorption time‐of‐flight mass spectrometryRapid Communications in Mass Spectrometry, 1995
- Chemical Modification of Fumagillin. I. 6-O-Acyl, 6-O-Sulfonyl, 6-O-Alkyl, and 6-O-(N-Substituted-carbamoyl)fumagillols.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- On the Mode of Action of the Immunosuppressive Sesquiterpene OvalicinEuropean Journal of Biochemistry, 1981
- Immunosuppressive effects of Ovalicin-semicarbazoneInflammation Research, 1974
- The Chemistry of Fumagillin1Journal of the American Chemical Society, 1961
- Fumagillin (H-3), a New Antibiotic with Amebicidal PropertiesScience, 1951